Community Answer

Answered by Dr. Emily Carter, MD

Mounjaro (tirzepatide) is primarily approved for the treatment of type 2 diabetes, not prediabetes. However, its use for prediabetes may be considered off-label in certain cases, depending on the patient's overall health profile and risk factors. Here’s what you should know:

  • FDA Approval: Mounjaro is approved for managing blood sugar levels in adults with type 2 diabetes, often in combination with diet and exercise.
  • Prediabetes: While not officially approved for prediabetes, some healthcare providers may prescribe it off-label if they believe it could help prevent the progression to type 2 diabetes.
  • Consult Your Doctor: Always consult your healthcare provider to determine if Mounjaro is appropriate for your specific condition.

For prediabetes, lifestyle changes such as weight loss, healthy eating, and regular exercise are typically the first line of defense.

Last updated: 1/15/2025